Abstract

PURPOSE. Experimental autoimmune anterior uveitis (EAAU) can be induced in Lewis rats with bovine melanin associated antigen (MAA) extracted from the iris/ciliary body (CB) and does not require adjuvant. The present investigation was undertaken to study the expression of various cytokines in EAAU. METHODS. Lewis rats were immunized with bovine MAA and sacrificed at various time points. The iris/CB and popliteal lymph nodes were harvested, and total RNA isolated. The reverse transcription polymerase chain reaction (RT-PCR) was utilized to determine the mRNA expression of IFN-?, TNF-a, IL-2, IL-4, IL-6 and IL-10. RESULTS. TNF-a mRNA levels in iris/CB paralleled the course of EAAU and increased dramatically at the peak of disease. However, mRNA levels of TNF-a demonstrated little change in the popliteal lymph node. IFN-? mRNA was barely detectable in the iris/CB and increased only slightly at the peak of disease. In contrast, IFN-? mRNA levels in the popliteal lymph node paralleled the course of disease and increased during the peak of disease. IL-10 mRNA did not change in the iris/CB but increased modestly in the popliteal lymph node. IL-2, IL-4, and IL-6 mRNA levels did not change during the course of EAAU in either tissue. CONCLUSIONS. Our study reveals an interesting correlation between the expression of TNF-a, IFN-? and disease progression in EAAU. Furthermore, they suggest that TNF-a is an important cytokine in the target tissue, while IFN-? is in the draining lymph node.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.